Two Go Fund Me pages and a benefit pool tournament have been created to help support Izzy Anderson's family as she continues ...

Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. A recent study leveraging ...

Brain cancer originates in the brain and consists of brain cancer cells. But brain metastases from lung cancer occur when cancer cells break off from the tumor in the lungs and enter the ...

COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

Metastatic castration-resistant prostate cancer (mCRPC) and its precursor, metastatic hormone sensitive prostate cancer (mHSPC), are advanced forms of the condition that don’t respond to initial ...

15.6 months. PFS benefits were consistent across subgroups, including those with exon 19 deletion, L858R mutation, and CNS metastases, demonstrating broad efficacy. The combination therapy was safe ...

However, it's impossible to remove and examine every lymph node and organ in the body to check for small cancer cells. Oncologists assume tiny, undetectable metastases may exist outside of the ...

Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. Frontiers JournalsNov 3 2024 ...

Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. A recent study leveraging ...

Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. A recent study leveraging ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...